PING WEI

Main Publications:

1, Wei, P.*, Wong, W.W.*, Park, J.S., Corcoran, E. E., Peisajovich, S. G., Onuffer, J, J., Weiss, A., Lim, W.A. Bacterial virulence proteins as tools to rewire kinase pathways in yeast and immune cells. Nature 2012; 488, 384-388. 
2, Peisajovich, S.G., Garbarino, J.E., Wei, P., Lim, W.A. Rapid diversification of cell signaling phenotypes by modular domain recombination. Science 2010; 328, 368-372
3, Liang H., Chen, H., Fan, F., Wei, P., Guo, X., Jin, C., Zeng, C., Tang, C., Lai, L. De novo design of a beta alpha beta motif. Angew Chem Int Ed Engl. 2009; 48(18):3301-3.
4, Chen, H.*, Wei, P.*, Huang, C., Tan, L., Liu, Y., Lai, L. Only one protomer is active in the dimer of SARS 3C-like proteinase. J. Biol. Chem. 2006; 281: 13894-13898. 
5, Wei, P.*, Fan, K.*, Chen, H., Ma, L., Huang, C., Tan, L., Xi, D., Li, C., Liu, Y., Cao, A., Lai, L. The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase. Biochem. Biophys. Res. Commun. 2006; 339: 865-872.
6, Fan, K.*, Wei, P.*, Feng, Q., Chen, S., Huang, C., Ma, L., Lai, B., Pei, J., Liu, Y., Chen, J., Lai, L. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. J. Biol. Chem. 2004; 279: 1637-1642.